In conclusion, previous studies reported an increase in serum tenascin-C levels in chronic autoimmune diseases, including RA, SLE, and scleroderma, yet tenascin-C levels do not increase in the autoinflammatory FMF disease. Here, TNC is linked to scleroderma.